Zentiva drug manufacturer registered a net profit of 143.025 million RON in the first half of this year, 97.7% higher than the one obtained in the same period of 2023, according to the data sent to the Bucharest Stock Exchange on Friday.(1 euro = 4.9769 RON)The company's turnover increased by 22.3%, from 450.6 million RON in the first six months of 2023 to 551.3 million RON in the first half of 2024, mainly due to the increase in sales of goods by 24%.External sales represented 39.98% of the total turnover (220.38 million RON), compared to 51.65% in the period January-June 2023 (232.76 million RON). The external sales of medicines were made through a company within the Zentiva Group (Zentiva k.s.) and were mainly intended for the markets of the European Union.The share of OTC products (medicines sold without a prescription) in the company's sales was 4.2% in the first semester of 2024, compared to 3.6% in the same period of 2023.Operating expenses increased by 5.5%, to 406.8 million RON. The variation in operating income and expenses led to an operating result for the first six months of 2024 of 144.6 million RON, compared to 65.2 million RON in the first half of 2023.During the mentioned period, the investments were 20.1 million RON and aimed at new production equipment and the modernization of the existing ones.The company, previously known as Sicomed SA Bucharest, was founded in 1962 as the Bucharest Medicines Company (IMB). In 1990, Sicomed became a joint-stock company, by incorporating and taking over the entire patrimony of the former IMB. The main object of activity is the production and sale of preparations and medicines for human use.Zentiva shares are traded in the Standard Category of the Bucharest Stock Exchange since 1998. Zentiva Group a.s. owns 95.9486% of the company's share capital.
The ECOTECA Association, in partnership with the Ministry of Environment, Waters and Forests, is organizing the conference “Return & Recycle Insights – 2 Years of DRS in Romania”, which will take place on 26 November 2025, between 09:00 – 13:00, at the Bucharest University of Economic Studies (ASE). The event will bring together representatives […]
Nine years after opening its doors, Veranda Mall enters its most exciting chapter yet. What began as a project to breathe new life into the Obor neighborhood has evolved into one of Bucharest’s most beloved destinations for shopping, leisure, and connection. As it marks this anniversary, Veranda unveils a winter events lineup rich in culture, […]
Purcari Wineries (BVB: WINE), CEE’s leading wine producer, announced its financial results for the first nine months of 2025 on Friday, November 14. The company saw a decline of 1.46% in pretax EBITDA earnings from the similar period last year. Specifically, earnings decreased to RON 84.66 million from RON 85.92 million last year. Meanwhile, group […]
With a solid 35-year uninterrupted presence on the Romanian market, Darian—one of the longest-standing consultancy groups with fully Romanian capital—reaffirms its role as a strategic partner for the business environment. Darian marks this anniversary not through grand promises, but by strengthening its core working philosophy: acting as a “co-pilot” for complex decision-making. The company emphasizes […]
The National Bank of Romania (BNR) revised its inflation forecast upward, from 8.8% to 9.6%, for the end of 2025. The institution anticipates that inflation will reach 3.7% at the end of 2026, compared to 3% in the previous forecast, according to data presented on Friday, November 14, by governor Mugur Isărescu. Compared to the […]
The state-owned company Transelectrica (BVB: TEL), the operator of the Romanian national energy system, recorded a net profit of RON 183 million in the first nine months of the year, down 56% compared to the same period last year. Operating revenues fell by 2%, to RON 1.716 billion, mainly due to the decrease in revenues […]
